Skip to content

Black rice health improvement project (study on the regulation and control effect of black rice on the metabolic state and vascular aging of patients with atherosclerotic cardiovascular disease)

Black rice health improvement project (study on the regulation and control effect of black rice on the metabolic state and vascular aging of patients with atherosclerotic cardiovascular disease)

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046061
Enrollment
Unknown
Registered
2021-05-03
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Study on the regulation of metabolic status and vascular aging in patients with atherosclerotic cardiovascular disease

Interventions

Control group:no
black rice intervention group:Black rice intervention

Sponsors

Union Hospital of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 45 to 65 years, regardless of gender; 2. Diagnosed as Atherosclerotic Cardiovascular Disease (ASCVD), which meets any of the following: atherosclerosis found on physical examination; chronic coronary syndrome; previous history of ischemic stroke or transient cerebral ischemia History of seizures; history of peripheral vascular disease; 3. Rice is the staple food, usually consuming more than 4 taels of rice per day; 4. Have not participated in other research projects at present or 3 months before the test; 5. Regular life, no more than 3 times a week to go out to eat and drink (referring to lunch and dinner); 6. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Allergic to black rice; 2. People who use drugs or alcohol; 3. Diabetes; 4. Severe gastrointestinal diseases, affecting the digestion and absorption of food; 5. Patients with severe liver and kidney disease; 6. Cancer patients or patients who have received radiotherapy or chemotherapy within 5 years; 7. Any mental illness; patients with epilepsy or using anti-epileptic therapy; people using antidepressants; 8. Suffer from infectious diseases such as AIDS, hepatitis A, hepatitis B and tuberculosis; 9. Those who are unable to take care of themselves or have limited mobility; 10. Pregnant or lactating women; 11. People whose daily diet contains a lot of anthocyanins.

Design outcomes

Primary

MeasureTime frame
pulse wave velocity;

Countries

China

Contacts

Public ContactHuang Kai

Union Hospital of Huazhong University of Science and Technology

huangkai1@hust.edu.cn+86 27 85726650

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026